Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
10.49
-0.30 (-2.78%)
At close: Oct 8, 2025, 4:00 PM EDT
10.52
+0.03 (0.29%)
After-hours: Oct 8, 2025, 4:24 PM EDT
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $171.24 million as of October 8, 2025. Its market cap has increased by 213.89% in one year.
Market Cap
171.24M
Enterprise Value
165.93M
1-Year Change
213.89%
Ranking
Category
Stock Price
$10.49
Market Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $171.24M, a decrease of -45.15%. That is a compound annual growth rate of -22.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 176.13M | 220.47% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
| Jun 2, 2023 | 312.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 764.87B |
| Johnson & Johnson | 455.85B |
| AbbVie | 409.51B |
| UnitedHealth Group | 337.96B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 232.21B |